Medication info
Cirtelmi Plus Tablets 80/12.5 mg

Cirtelmi Plus Tablets 80/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
HLB Pharmaceuticals Co., Ltd.
Appearance
White or almost white, biconvex, round tablets
Packaging
30 tablets/box [10 tablets/blister X 3]
Approval status
Active

MFDS item code 201804358 · Approved 2018.11.01 · Insurance code 647303520

Summary

Main use
Treatment of essential hypertension not adequately controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, in which the doses of each component are fixed, it is recommended to adjust the dose of each component individually. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given together as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose of this medicine must not exceed 40/12.5mg. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with hepatic impairment. Older adults No dosage adjustment is necessary.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
HLB Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled with telmisartan alone. It helps manage blood pressure more effectively and aids in the prevention of complications.

How to take

Adult dose

Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, in which the doses of each component are fixed, it is recommended to adjust the dose of each component individually. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given together as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose of this medicine must not exceed 40/12.5mg. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with hepatic impairment. Older adults No dosage adjustment is necessary.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. It should not be used in patients who have allergies to specific components or have severely impaired liver or kidney function. Elderly patients or those with high potassium levels or liver dysfunction should use this medication with caution. Side effects such as dizziness, low blood pressure, and electrolyte imbalance may occur during treatment, so regular monitoring is necessary. The hydrochlorothiazide component can affect the balance of body fluids and electrolytes, so patients in a dehydrated state should be cautious. This medication may interact with other antihypertensives, lithium preparations, potassium supplements, etc., so it is essential to inform the healthcare provider about any medications being taken. If pregnancy is confirmed, the use of this medication should be stopped immediately, and consultation with a healthcare professional is advised; it is also best to avoid using this medication while breastfeeding. Overdose may cause low blood pressure, electrolyte abnormalities, and dehydration symptoms, requiring immediate medical attention. It is not recommended for use in children as safety and efficacy have not been established in the pediatric population. It is important to keep this medication out of the reach of children and take it out of the packaging just before use.

Side effects

Hypotension, neonatal skull formation deficiency, anuria, renal failure, oligohydramnios, limb convulsions, craniofacial malformation, pulmonary hypoplasia, premature, intrauterine growth retardation, patent ductus arteriosus, bronchitis, pharyngitis, sinusitis, hypokalemia, hyperuricemia, hyponatremia, anxiety, depression, insomnia, sleep disorder, dizziness, syncope, paresthesia, visual impairment, blurred vision, vertigo, tachycardia, arrhythmia, hypotension, orthostatic hypotension, dyspnea, respiratory pain, lung inflammation, pulmonary edema, diarrhea, dry mouth, distension, abdominal pain, constipation, dyspepsia, vomiting, gastritis, liver dysfunction, hepatic impairment, vascular edema, erythema, pruritus, rash, sweating, urticaria, back pain, muscle spasms, myalgia, arthralgia, limb pain, systemic lupus erythematosus, erectile dysfunction, chest pain, influenza-like illness, pain, increased uric acid in blood, increased creatinine in blood, elevated creatine phosphokinase enzyme in blood, increased liver enzymes, upper respiratory infection, urinary tract infection, cystitis, sepsis, anemia, eosinophilia, thrombocytopenia, anaphylactic reaction, hyperkalemia, hypoglycemia, drowsiness, bradycardia, cough, interstitial lung disease, dry mouth, abdominal discomfort, taste disturbance, eczema, drug rash, toxic skin eruption, bone pain, renal dysfunction, asthenia, influenza-like illness, increased creatinine in blood, decreased hemoglobin, sialadenitis, non-melanoma skin cancer, thrombocytopenic purpura, hemolytic anemia, bone marrow failure, leukopenia, agranulocytosis, hypersensitivity, aplastic anemia, dyslipidemia, decreased appetite, hypomagnesemia, hyperglycemia, hypercalcemia, hypochloremic alkalosis, jaundice, cholestasis, photosensitivity reaction, toxic epidermal necrolysis, lupus-like syndrome, systemic lupus erythematosus, acute renal failure, diabetes, asthenia, fever, dizziness, itching, myalgia, headache, floating sensation, nausea, gastrointestinal bleeding, esophagitis, fatigue, weight loss, proteinuria, lip and hand tremors, hypersensitivity, decreased vision, hypotension, tachycardia, bradycardia, vascular edema, thrombocytopenia, thrombocytopenic purpura, hemolytic anemia, bone marrow failure, leukopenia, agranulocytosis, hypersensitivity, anaphylactic reaction, hypokalemia, dyslipidemia, hyponatremia, hyperuricemia, depression, sleep disorder, dizziness, paresthesia, headache, visual impairment, arrhythmia, orthostatic hypotension, necrotizing vasculitis, respiratory pain, lung inflammation, pulmonary edema, acute respiratory distress syndrome, diarrhea, nausea, vomiting, constipation, abdominal discomfort, pancreatitis, jaundice, cholestasis, rash, urticaria, photosensitivity reaction, toxic epidermal necrolysis, lupus-like syndrome, systemic lupus erythematosus, muscle spasms, acute renal failure, erectile dysfunction, asthenia, fever, dizziness, cough, itching, myalgia, headache, floating sensation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to protect it from air and moisture. Additionally, it should be kept at room temperature between 1 to 30 degrees Celsius, away from extreme heat or cold.

Appearance and packaging

Appearance

White or almost white, biconvex, round tablets

Package unit

30 tablets/box [10 tablets/blister X 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.